VETTF yields 7.17% · JNJ yields 2.13%● Live data
📍 VETTF pulled ahead of the other in Year 1
Combined, VETTF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VETTF + JNJ for your $10,000?
Vector Limited, together with its subsidiaries, engages in electricity and gas distribution, natural gas and LPG sale, gas processing, metering, and telecommunication and new energy solutions businesses in New Zealand. The company operates through Regulated Networks, Gas Trading, and Metering segments. It distributes electricity to residential and commercial customers in Auckland, from Wellsford to Papakura through its network consisting of approximately 18,000 kilometers of overhead lines and underground cables; bulk LPG to commercial customers; and bottled LPG to commercial and residential customers, as well as processes, trades, and sells natural gas. The company also provides Vector solar systems; electricity and gas metering, and data services to approximately 2,000,000 homes and businesses; and designs, builds, and supports fiber network solutions that connect approximately 800 buildings in Auckland. In addition, it offers electric vehicle charging station app; bulk LPG storage, distribution, and management services; trustee and technology services; and ventilation, heating, and water systems and related assembly services. The company is headquartered in Auckland, New Zealand. Vector Limited is a subsidiary of Entrust.
Full VETTF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.